CATSPERG: A Potential Drug Target and Biomarker for Cancer (G57828)

Target Name: CATSPERG

NCBI ID: G57828

CATSPERG

Other Name(s): C19orf15 | CATSPERG variant 1 | cation channel sperm-associated protein subunit gamma | cation channel sperm associated auxiliary subunit gamma | CTSRG_HUMAN | Cation channel sperm-associated auxiliary subunit gamma (isoform 1) | catsper channel auxiliary subunit gamma | Cation channel sperm associated auxiliary subunit gamma, transcript variant 1 | Cation channel sperm-associated protein subunit gamma

CATSPERG: A Potential Drug Target and Biomarker for Cancer

CATSPERG, also known as C19orf15, is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. The gene is located on chromosome 19 and encodes a protein known as cathepsin X.

Cathepsin X is a member of the cathepsin family, which is a group of proteins that are involved in various cellular processes, including inflammation and stress responses. The cathepsin family has been implicated in the development and progression of many diseases, including cancer.

Research has shown that changes in the levels of cathepsin X have been observed in various diseases, including cancer. For example, studies have shown that high levels of cathepsin X have been associated with an increased risk of certain types of cancer, such as lung cancer and ovarian cancer.

In addition to its potential as a drug target, CATSPERG has also been identified as a potential biomarker for cancer. The protein encoded by this gene has been shown to be expressed in a variety of tissues and fluids, including blood, urine, and breast tissue. This suggests that it may be a useful biomarker for tracking the spread of cancer and evaluating the effectiveness of treatments.

Another potential application of CATSPERG as a drug target is its role in modulating inflammation. The cathepsin family has been shown to play a role in the regulation of inflammation and immune responses. By targeting CATSPERG, researchers may be able to develop new treatments for inflammatory diseases.

While more research is needed to fully understand the potential implications of CATSPERG as a drug target and biomarker, its identification as a promising target for cancer research is an exciting development in the field of medicine. As research continues to progress, the potential of CATSPERG as a new treatment option for a variety of diseases may become clear.

Protein Name: Cation Channel Sperm Associated Auxiliary Subunit Gamma

Functions: Auxiliary component of the CatSper complex, a complex involved in sperm cell hyperactivation. Sperm cell hyperactivation is needed for sperm motility which is essential late in the preparation of sperm for fertilization

The "CATSPERG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CATSPERG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets